Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247


Hyperacute-phase computed tomography-diffusion-weighted imaging discrepancy and response to thrombolysis.

Kawano H, Hirano T, Inatomi Y, Terasaki T, Yonehara T, Uchino M.

J Stroke Cerebrovasc Dis. 2013 May;22(4):290-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.09.001. Epub 2011 Oct 13.


Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.

Kawano H, Hirano T, Inatomi Y, Terasaki T, Yonehara T, Uchino M.

Cerebrovasc Dis. 2010 Aug;30(3):230-6. doi: 10.1159/000317183. Epub 2010 Jul 1.


Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.

Kimura K, Iguchi Y, Shibazaki K, Terasawa Y, Inoue T, Uemura J, Aoki J.

Stroke. 2008 Aug;39(8):2388-91. doi: 10.1161/STROKEAHA.107.510917. Epub 2008 Jun 5.


Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.

Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Kario K, Naganuma M, Maeda K, Minematsu K, Toyoda K.

Stroke. 2011 Aug;42(8):2196-200. doi: 10.1161/STROKEAHA.111.614404. Epub 2011 Jun 30.


Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.

Yeo LL, Paliwal P, Teoh HL, Seet RC, Chan BP, Wakerley B, Liang S, Rathakrishnan R, Chong VF, Ting EY, Sharma VK.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e590-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.024. Epub 2013 Aug 15.


Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.

Sakamoto Y, Koga M, Kimura K, Nagatsuka K, Okuda S, Kario K, Hasegawa Y, Okada Y, Yamagami H, Furui E, Nakagawara J, Shiokawa Y, Okata T, Kobayashi J, Tanaka E, Minematsu K, Toyoda K.

Eur J Neurol. 2014 Mar;21(3):419-26. doi: 10.1111/ene.12308. Epub 2013 Nov 22.


Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.

Koga M, Arihiro S, Miyashita F, Yamamoto H, Yamada N, Nagatsuka K, Minematsu K, Toyoda K.

Cerebrovasc Dis. 2013;36(4):299-305. doi: 10.1159/000355054. Epub 2013 Oct 16.


Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.

Deguchi I, Takeda H, Furuya D, Dembo T, Nagoya H, Kato Y, Ito Y, Fukuoka T, Maruyama H, Tanahashi N.

J Stroke Cerebrovasc Dis. 2012 Feb;21(2):108-13. doi: 10.1016/j.jstrokecerebrovasdis.2010.03.019. Epub 2010 Sep 19. Erratum in: J Stroke Cerebrovasc Dis. 2012 May;21(4):342.


Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.

Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W.

Stroke. 2000 Jun;31(6):1318-28.


Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.


Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.

Deguchi I, Dembo T, Yoshimura S, Sakai N, Okada Y, Kitagawa K, Kimura K, Hyogo T, Yamagami H, Egashira Y, Tanahashi N.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1471-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.053. Epub 2014 Mar 28.


Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.


Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.

Hirano T, Sasaki M, Tomura N, Ito Y, Kobayashi S; Japan Alteplase Clinical Trial Group.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):898-902. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.018. Epub 2011 Jul 7.


Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.

Turc G, Apoil M, Naggara O, Calvet D, Lamy C, Tataru AM, Méder JF, Mas JL, Baron JC, Oppenheim C, Touzé E.

Stroke. 2013 May;44(5):1323-8. doi: 10.1161/STROKEAHA.111.000127. Epub 2013 Mar 12.


Could clinical diffusion-mismatch determined using DWI ASPECTS predict neurological improvement after thrombolysis before 3 h after acute stroke?

Terasawa Y, Kimura K, Iguchi Y, Kobayashi K, Aoki J, Shibazaki K, Kaji R.

J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):864-8. doi: 10.1136/jnnp.2009.190140. Epub 2010 Jun 19.


Total mismatch: negative diffusion-weighted imaging but extensive perfusion defect in acute stroke.

Cho TH, Hermier M, Alawneh JA, Ritzenthaler T, Desestret V, Østergaard L, Derex L, Baron JC, Nighoghossian N.

Stroke. 2009 Oct;40(10):3400-2. doi: 10.1161/STROKEAHA.109.563064. Epub 2009 Aug 20.


[ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].

Idei M, Sasaki T, Tanabe T, Muraoka K, Terada K, Meguro T, Hirotsune N, Nishino S.

No Shinkei Geka. 2012 Jul;40(7):585-91. Japanese.


Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.

Mittal MK, Seet RC, Zhang Y, Brown RD Jr, Rabinstein AA.

J Stroke Cerebrovasc Dis. 2013 Jul;22(5):639-43. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.009. Epub 2012 Feb 15. Review.


Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.

Lee KH, Lee SJ, Cho SJ, Na DG, Byun HS, Kim YB, Song HJ, Jin IS, Chung CS.

Arch Neurol. 2000 Jul;57(7):1000-8.


Supplemental Content

Support Center